These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 7065237

  • 1. Autoregulation of rat pituitary prolactin secretion demonstrated by a new perfusion method.
    Zacur HA, Mitch WE, Tyson JE, Ostrow PT, Foster GV.
    Am J Physiol; 1982 Apr; 242(4):E226-33. PubMed ID: 7065237
    [Abstract] [Full Text] [Related]

  • 2. Pituitaries transplanted under the renal capsule contain functional growth hormone (GH) secretors and suppress GH and prolactin release from individual eutopic pituitary cells.
    Porter TE, Chen TT, Frawley LS.
    Endocrinology; 1989 Dec; 125(6):3059-67. PubMed ID: 2510989
    [Abstract] [Full Text] [Related]

  • 3. The effects of dopamine, bromocriptine, lergotrile and metoclopramide on prolactin release from continuously perfused columns of isolated rat pituitary cells.
    Yeo T, Thorner MO, Jones A, Lowry PJ, Besser GM.
    Clin Endocrinol (Oxf); 1979 Feb; 10(2):123-30. PubMed ID: 34491
    [Abstract] [Full Text] [Related]

  • 4. Normal and adenomatous human pituitaries secrete thyrotropin-releasing hormone in vitro: modulation by dopamine, haloperidol, and somatostatin.
    Le Dafniet M, Lefebvre P, Barret A, Mechain C, Feinstein MC, Brandi AM, Peillon F.
    J Clin Endocrinol Metab; 1990 Aug; 71(2):480-6. PubMed ID: 1974264
    [Abstract] [Full Text] [Related]

  • 5. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M, Yamaji T.
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [Abstract] [Full Text] [Related]

  • 6. Dopamine inhibits maitotoxin-stimulated pituitary 45Ca2+ efflux and prolactin release.
    Login IS, Judd AM, MacLeod RM.
    Am J Physiol; 1986 Jun; 250(6 Pt 1):E731-5. PubMed ID: 3717333
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vitro and in vivo antagonistic regulation by estradiol and progesterone of the rat pituitary domperidone binding sites: correlation with ovarian steroid regulation of the dopaminergic inhibition of prolactin secretion in vitro.
    Bression D, Brandi AM, Pagesy P, Le Dafniet M, Martinet M, Brailly S, Michard M, Peillon F.
    Endocrinology; 1985 May; 116(5):1905-11. PubMed ID: 3987624
    [Abstract] [Full Text] [Related]

  • 11. Hyperprolactinemia after neonatal prolactin (PRL) deficiency in rats: evidence for altered anterior pituitary regulation of PRL secretion.
    Shah GV, Shyr SW, Grosvenor CE, Crowley WR.
    Endocrinology; 1988 May; 122(5):1883-9. PubMed ID: 3129278
    [Abstract] [Full Text] [Related]

  • 12. Release of dynorphin-like immunoreactivity from rat adenohypophysis in vitro during inhibition of anterior pituitary hormone secretion from individual cell types.
    Schwaninger M, Knepel W, Döhler KD, Sandow J.
    Endocrinology; 1987 Jul; 121(1):167-74. PubMed ID: 2885174
    [Abstract] [Full Text] [Related]

  • 13. Prolactin suppresses luteinizing hormone secretion and pituitary responsiveness to luteinizing hormone-releasing hormone by a direct action at the anterior pituitary.
    Cheung CY.
    Endocrinology; 1983 Aug; 113(2):632-8. PubMed ID: 6347662
    [Abstract] [Full Text] [Related]

  • 14. Acute effect of basic fibroblast growth factor on secretion of prolactin as assessed by the reverse hemolytic plaque assay.
    Larson GH, Koos RD, Sortino MA, Wise PM.
    Endocrinology; 1990 Feb; 126(2):927-32. PubMed ID: 2105207
    [Abstract] [Full Text] [Related]

  • 15. Interaction of thyrotropin-releasing hormone and dopamine on the release of prolactin from the rat anterior pituitary in vitro.
    Hill-Samli M, MacLeod RM.
    Endocrinology; 1974 Oct; 95(4):1189-92. PubMed ID: 4213193
    [No Abstract] [Full Text] [Related]

  • 16. Resumption of prolactin secretion after dopaminergic inhibition: differential effects of dopamine and its agonists.
    Woolf PD.
    Am J Physiol; 1981 Jun; 240(6):E700-4. PubMed ID: 7246736
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evidence that the dopaminergic prolactin-inhibiting factor mechanism regulates only the depletion-transformation phase and not the release phase of prolactin secretion during suckling in the rat.
    Grosvenor CE, Mena F, Whitworth NS.
    Endocrinology; 1980 Feb; 106(2):481-5. PubMed ID: 7353523
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.